BR0102322A - Vìrus de uma cepa de vìrus de doença bursal infecciosa, vacina contra doença bursal infecciosa, métodos para a preparação do vìrus, e da vacina, e, uso do vìrus - Google Patents

Vìrus de uma cepa de vìrus de doença bursal infecciosa, vacina contra doença bursal infecciosa, métodos para a preparação do vìrus, e da vacina, e, uso do vìrus

Info

Publication number
BR0102322A
BR0102322A BR0102322A BR0102322A BR0102322A BR 0102322 A BR0102322 A BR 0102322A BR 0102322 A BR0102322 A BR 0102322A BR 0102322 A BR0102322 A BR 0102322A BR 0102322 A BR0102322 A BR 0102322A
Authority
BR
Brazil
Prior art keywords
virus
bursal disease
infectious bursal
vaccine
preparing
Prior art date
Application number
BR0102322A
Other languages
English (en)
Inventor
Egbert Mundt
Adriaan Antonius Wilhelmu Loon
Original Assignee
Akzo Nobel Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akzo Nobel Nv filed Critical Akzo Nobel Nv
Publication of BR0102322A publication Critical patent/BR0102322A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2720/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsRNA viruses
    • C12N2720/00011—Details
    • C12N2720/10011—Birnaviridae
    • C12N2720/10021—Viruses as such, e.g. new isolates, mutants or their genomic sequences
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2720/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsRNA viruses
    • C12N2720/00011—Details
    • C12N2720/10011—Birnaviridae
    • C12N2720/10034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Abstract

"VìRUS DE UMA CEPA DE VìRUS DE DOENçA BURSAL INFECCIOSA, VACINA CONTRA DOENçA BURSAL INFECCIOSA, MéTODOS PARA A PREPARAçãO DO VìRUS, E DA VACINA, E, USO DO VìRUS". A presente invenção provê um novo virus de doença bursal infecciosa, cepa 689, que é apropriado como candidato de vacina para vacinação in ovo e é depositado na European Collection of Cell Culture, Salisbury, Wiltshire, Reino Unido, sob o número de acesso V00012609.
BR0102322A 2000-06-09 2001-06-08 Vìrus de uma cepa de vìrus de doença bursal infecciosa, vacina contra doença bursal infecciosa, métodos para a preparação do vìrus, e da vacina, e, uso do vìrus BR0102322A (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP00202042 2000-06-09

Publications (1)

Publication Number Publication Date
BR0102322A true BR0102322A (pt) 2002-02-13

Family

ID=8171620

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0102322A BR0102322A (pt) 2000-06-09 2001-06-08 Vìrus de uma cepa de vìrus de doença bursal infecciosa, vacina contra doença bursal infecciosa, métodos para a preparação do vìrus, e da vacina, e, uso do vìrus

Country Status (9)

Country Link
US (2) US6451321B1 (pt)
JP (1) JP2002045175A (pt)
KR (1) KR20020013378A (pt)
AU (1) AU782013B2 (pt)
BR (1) BR0102322A (pt)
CA (1) CA2349960A1 (pt)
HU (1) HUP0102389A3 (pt)
MX (1) MXPA01005808A (pt)
ZA (1) ZA200104596B (pt)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA200104596B (en) * 2000-06-09 2001-12-06 Akzo Nobel Nv IBDV strain for in ovo administration.
JP2002153262A (ja) * 2000-11-20 2002-05-28 Shibuya Kogyo Co Ltd 鶏卵の処理方法および処理装置
AU2002235158A1 (en) * 2000-12-01 2002-06-11 Vigilos, Inc. System and method for processing video data utilizing motion detection and subdivided video fields
WO2005049794A2 (en) 2003-11-13 2005-06-02 University Of Georgia Research Foundation, Inc. Methods of characterizing infectious bursal disease virus
WO2005100554A1 (ja) * 2004-03-31 2005-10-27 Juridical Foundation The Chemo-Sero-Therapeutic Research Institute 新規な伝染性ファブリキウス嚢病ウイルス、及び当該ウイルスを含有するワクチン
US7491399B2 (en) * 2005-06-23 2009-02-17 University Of Maryland Biotechnology Institute In Ovo vaccine against infectious bursal disease
US20100003279A1 (en) * 2005-12-22 2010-01-07 Juridical Foundation The Chemo-Sero-Therapeutic Research Institute Vaccine for in ovo inoculation
RU2561673C2 (ru) * 2006-03-30 2015-08-27 Эмбрекс, Инк. Способы и композиции для вакцинации домашней птицы
GB2451428A (en) * 2007-07-25 2009-02-04 Pliva Hrvatska D O O Process for preparing an in ovo combination viral vaccine

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5192539A (en) 1988-07-21 1993-03-09 Akzo N.V. Infectious bursal disease virus production in continuous cell lines
CA2066661C (en) * 1989-10-02 2001-05-08 Craig E. Whitfill Viral vaccine conjugates
EP0861665A1 (en) 1997-02-03 1998-09-02 Dimminaco Ag/Sa/Ltd. Infectious bursitis vaccine
EP1161953A3 (en) * 2000-06-09 2004-02-04 Akzo Nobel N.V. IBDV strain for in OVO administration
ZA200104596B (en) * 2000-06-09 2001-12-06 Akzo Nobel Nv IBDV strain for in ovo administration.

Also Published As

Publication number Publication date
MXPA01005808A (es) 2004-11-10
CA2349960A1 (en) 2001-12-09
AU782013B2 (en) 2005-06-30
KR20020013378A (ko) 2002-02-20
US20030068334A1 (en) 2003-04-10
AU5179101A (en) 2002-01-03
ZA200104596B (en) 2001-12-06
HUP0102389A2 (hu) 2002-04-29
HUP0102389A3 (en) 2005-06-28
JP2002045175A (ja) 2002-02-12
US6451321B1 (en) 2002-09-17
HU0102389D0 (en) 2001-08-28

Similar Documents

Publication Publication Date Title
EA200900784A1 (ru) Вакцины, включающие антиген из четырех штаммов вируса гриппа
ES2762535T3 (es) Virus de la pseudorrabia de los porcinos, composición de vacuna y método de preparación y uso de la misma
AR013063A1 (es) Formula de vacuna aviaria, su utilizacion y kit de vacunacion
García et al. Commercial vaccines and vaccination strategies against infectious laryngotracheitis: what we have learned and knowledge gaps that remain
EP2465919A2 (en) Process of manufacturing viral vaccines in suspension avian embryonic derived stem cell lines
BR0102322A (pt) Vìrus de uma cepa de vìrus de doença bursal infecciosa, vacina contra doença bursal infecciosa, métodos para a preparação do vìrus, e da vacina, e, uso do vìrus
EA200801756A1 (ru) Противогриппозные вакцины, содержащие гемагглютинин и белки матрикса
BR0015846A (pt) Método para a produção de um vìrus e/ou proteìnas virais diferentes de adenovìrus ou proteìnas adenovirais, uso de uma célula humana, vìrus ou proteìna viral para uso em uma vacina obtenìvel por meio dos citados métodos e uso, célula humana kit para determinar a atividade de uma protease em uma amostra, uso de uma proteìna viral ou um vìrus, método para concentrar vìrus influenza em condições capazes de, pelo menos em parte,preservar a capacidade de infecção do vìrus, e, vìrus influenza infeccioso ou seus derivados.
AR059828A2 (es) Formula de vacuna para equidos, su utilizacion y kit de vacunacion
MY163972A (en) Attenuated recombinant newcastle disease virus and vaccine containing the same
DE60044672D1 (de) Auf dem isolat ja-142 basierender impfstoff gegen das reproduktive-und-respiratorische syndrom beim schwein
Cavanagh et al. Manipulation of the infectious bronchitis coronavirus genome for vaccine development and analysis of the accessory proteins
Wang et al. Changes in VP2 gene during the attenuation of very virulent infectious bursal disease virus strain Gx isolated in China
BR9712012A (pt) Método para gerar birnavìrus a partir de trancritos de rna sintético.
UA84667C2 (ru) Вакцина, направленная против инфекции, вызванной вирусом герпеса болезни марека
BR112023019301A2 (pt) Formulações de vacina de coronavírus
ATE474596T1 (de) Impfstoff gegen humanes papillomavirus zur oralen verabreichung
RU2004126695A (ru) Непрерывная клеточная линия для получения вакцин
EP1161953A3 (en) IBDV strain for in OVO administration
UA100849C2 (ru) Способ репликации вируса гриппа в культуре
BRPI0408643A (pt) mutante de vìrus clássico de doença bursal infecciosa, vacina para uso na proteção de aves domésticas, e, métodos para a preparação de um mutante de vìrus clássico de doença bursal infecciosa e para a preparação de uma vacina
DOP2014000215A (es) Virus de la enfermedad de marek modificado y vacunas elaboradas con él
Wang et al. Construction, identification, and immunogenic assessments of an HSV-1 mutant vaccine with a UL18 deletion
TW200710224A (en) Attenuated avian infectious bronchitis virus vaccines
FR3089789B1 (fr) Production de vaccins viraux sur une lignee cellulaire aviaire

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 6A , 7A E 8A ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 DA RPI 2012 DE 28/07/2009.